Perbedaan Bank Mandiri Persero Tbk dan Brigit Biofarmaka Teknologi Tbk.: Bank Mandiri Persero Tbk diperdagangkan di Rp4.130 (kapitalisasi pasar 381,61 T, volume 24 jam 108,71 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp242 (kapitalisasi pasar 164,65 M, volume 24 jam 187,4 rb). Perbedaan utamanya: Bank Mandiri Persero Tbk jauh lebih besar — sekitar 2317,7× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Bank Mandiri Persero Tbk lebih aktif diperdagangkan (108,71 jt vs 187,4 rb). Mana yang lebih baik tergantung tujuan investasimu.
| BMRI | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 381,61 T | 164,65 M |
Volume | 108,71 jt | 187,4 rb |
Lot | 1,09 jt | 1,87 rb |
Perputaran | 447,18 M | 44,35 jt |
Harga Rata-rata | 4.113,54 | 236,67 |
Nilai Transaksi | 447,18 M | 44,35 jt |
Harga Ekuilibrium Indikatif | 4.130 | 242 |
Volume Ekuilibrium Indikatif | 185,32 rb | 500 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
Bank Mandiri was established at 2 Oct 1998 and start in commercial activity at 1 Aug 1999. As a result of merge 4 banks (Bank Bumi Daya, Bank Dagang Negara, Bank Exim and Bapindo), Bank Mandiri is Indonesia's largest national bank (assets) as per Dec 31, 2002. Bank Mandiri main activities are corporate banking, commercial banking and consumer banking.
Selengkapnya di halaman BMRI →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →